Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy.

MLA

Kumar, Nathella Pavan, et al. “Systemic RAGE Ligands Are Upregulated in Tuberculosis Individuals with Diabetes Co-Morbidity and Modulated by Anti-Tuberculosis Treatment and Metformin Therapy.” BMC Infectious Diseases, vol. 19, no. 1, Dec. 2019, p. 1039. EBSCOhost, https://doi.org/10.1186/s12879-019-4648-1.

APA

Kumar, N. P., Moideen, K., Nancy, A., Viswanathan, V., Shruthi, B. S., Sivakumar, S., Hissar, S., Kornfeld, H., & Babu, S. (2019). Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy. BMC Infectious Diseases, 19(1), 1039. https://doi.org/10.1186/s12879-019-4648-1

Chicago

Kumar, Nathella Pavan, Kadar Moideen, Arul Nancy, Vijay Viswanathan, Basavaradhya S Shruthi, Shanmugam Sivakumar, Syed Hissar, Hardy Kornfeld, and Subash Babu. 2019. “Systemic RAGE Ligands Are Upregulated in Tuberculosis Individuals with Diabetes Co-Morbidity and Modulated by Anti-Tuberculosis Treatment and Metformin Therapy.” BMC Infectious Diseases 19 (1): 1039. doi:10.1186/s12879-019-4648-1.